0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fully Humanized Monoclonal Antibody Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-13B18288
Home | Market Reports | Science| Biological Sciences
Global Fully Humanized Monoclonal Antibody Market Research Report 2024
BUY CHAPTERS

Global Fully Humanized Monoclonal Antibody Market Research Report 2024

Code: QYRE-Auto-13B18288
Report
September 2024
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Fully Humanized Monoclonal Antibody Market Size

The global Fully Humanized Monoclonal Antibody market was valued at US$ 2211 million in 2023 and is anticipated to reach US$ 5369 million by 2030, witnessing a CAGR of 13.7% during the forecast period 2024-2030.

Fully Humanized Monoclonal Antibody Market

Fully Humanized Monoclonal Antibody Market

Fully Humanized Monoclonal Antibody is an antibody that has been entirely engineered from human sources, with no original non-human components. Unlike humanized monoclonal antibodies, which retain some animal-derived regions, fully humanized antibodies are created using techniques like phage display or transgenic mice to produce antibodies that are completely derived from human genes. This results in antibodies that are more likely to be well-tolerated by the human immune system, reducing the risk of adverse reactions and making them ideal for therapeutic applications, such as treating cancer, autoimmune diseases, and infectious diseases.
North American market for Fully Humanized Monoclonal Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fully Humanized Monoclonal Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Fully Humanized Monoclonal Antibody in Laboratory Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Fully Humanized Monoclonal Antibody include GenScript ProBio, Biotem, Creative Biolabs, ProMab Biotechnologies, ProteoGenix, Absolute Antibody, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Fully Humanized Monoclonal Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fully Humanized Monoclonal Antibody.
The Fully Humanized Monoclonal Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fully Humanized Monoclonal Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fully Humanized Monoclonal Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Fully Humanized Monoclonal Antibody Market Report

Report Metric Details
Report Name Fully Humanized Monoclonal Antibody Market
Accounted market size in 2023 US$ 2211 million
Forecasted market size in 2030 US$ 5369 million
CAGR 13.7%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
  • Laboratory Research
  • Clinical Drugs
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GenScript ProBio, Biotem, Creative Biolabs, ProMab Biotechnologies, ProteoGenix, Absolute Antibody
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Fully Humanized Monoclonal Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Fully Humanized Monoclonal Antibody Market growing?

Ans: The Fully Humanized Monoclonal Antibody Market witnessing a CAGR of 13.7% during the forecast period 2024-2030.

What is the Fully Humanized Monoclonal Antibody Market size in 2030?

Ans: The Fully Humanized Monoclonal Antibody Market size in 2030 will be US$ 5369 million.

Who are the main players in the Fully Humanized Monoclonal Antibody Market report?

Ans: The main players in the Fully Humanized Monoclonal Antibody Market are GenScript ProBio, Biotem, Creative Biolabs, ProMab Biotechnologies, ProteoGenix, Absolute Antibody

What are the Application segmentation covered in the Fully Humanized Monoclonal Antibody Market report?

Ans: The Applications covered in the Fully Humanized Monoclonal Antibody Market report are Laboratory Research, Clinical Drugs

What are the Type segmentation covered in the Fully Humanized Monoclonal Antibody Market report?

Ans: The Types covered in the Fully Humanized Monoclonal Antibody Market report are IgG Type, IgM Type, IgA Type, Others

Recommended Reports

Monoclonal Antibodies

Antibody Therapeutics

Humanized Models & Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fully Humanized Monoclonal Antibody Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 IgG Type
1.2.3 IgM Type
1.2.4 IgA Type
1.2.5 Others
1.3 Market by Application
1.3.1 Global Fully Humanized Monoclonal Antibody Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Laboratory Research
1.3.3 Clinical Drugs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fully Humanized Monoclonal Antibody Market Perspective (2019-2030)
2.2 Global Fully Humanized Monoclonal Antibody Growth Trends by Region
2.2.1 Global Fully Humanized Monoclonal Antibody Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Fully Humanized Monoclonal Antibody Historic Market Size by Region (2019-2024)
2.2.3 Fully Humanized Monoclonal Antibody Forecasted Market Size by Region (2025-2030)
2.3 Fully Humanized Monoclonal Antibody Market Dynamics
2.3.1 Fully Humanized Monoclonal Antibody Industry Trends
2.3.2 Fully Humanized Monoclonal Antibody Market Drivers
2.3.3 Fully Humanized Monoclonal Antibody Market Challenges
2.3.4 Fully Humanized Monoclonal Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fully Humanized Monoclonal Antibody Players by Revenue
3.1.1 Global Top Fully Humanized Monoclonal Antibody Players by Revenue (2019-2024)
3.1.2 Global Fully Humanized Monoclonal Antibody Revenue Market Share by Players (2019-2024)
3.2 Global Fully Humanized Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Fully Humanized Monoclonal Antibody Revenue
3.4 Global Fully Humanized Monoclonal Antibody Market Concentration Ratio
3.4.1 Global Fully Humanized Monoclonal Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fully Humanized Monoclonal Antibody Revenue in 2023
3.5 Global Key Players of Fully Humanized Monoclonal Antibody Head office and Area Served
3.6 Global Key Players of Fully Humanized Monoclonal Antibody, Product and Application
3.7 Global Key Players of Fully Humanized Monoclonal Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Fully Humanized Monoclonal Antibody Breakdown Data by Type
4.1 Global Fully Humanized Monoclonal Antibody Historic Market Size by Type (2019-2024)
4.2 Global Fully Humanized Monoclonal Antibody Forecasted Market Size by Type (2025-2030)
5 Fully Humanized Monoclonal Antibody Breakdown Data by Application
5.1 Global Fully Humanized Monoclonal Antibody Historic Market Size by Application (2019-2024)
5.2 Global Fully Humanized Monoclonal Antibody Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Fully Humanized Monoclonal Antibody Market Size (2019-2030)
6.2 North America Fully Humanized Monoclonal Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Fully Humanized Monoclonal Antibody Market Size by Country (2019-2024)
6.4 North America Fully Humanized Monoclonal Antibody Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fully Humanized Monoclonal Antibody Market Size (2019-2030)
7.2 Europe Fully Humanized Monoclonal Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Fully Humanized Monoclonal Antibody Market Size by Country (2019-2024)
7.4 Europe Fully Humanized Monoclonal Antibody Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fully Humanized Monoclonal Antibody Market Size (2019-2030)
8.2 Asia-Pacific Fully Humanized Monoclonal Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Fully Humanized Monoclonal Antibody Market Size by Region (2019-2024)
8.4 Asia-Pacific Fully Humanized Monoclonal Antibody Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fully Humanized Monoclonal Antibody Market Size (2019-2030)
9.2 Latin America Fully Humanized Monoclonal Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Fully Humanized Monoclonal Antibody Market Size by Country (2019-2024)
9.4 Latin America Fully Humanized Monoclonal Antibody Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fully Humanized Monoclonal Antibody Market Size (2019-2030)
10.2 Middle East & Africa Fully Humanized Monoclonal Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Fully Humanized Monoclonal Antibody Market Size by Country (2019-2024)
10.4 Middle East & Africa Fully Humanized Monoclonal Antibody Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript ProBio
11.1.1 GenScript ProBio Company Details
11.1.2 GenScript ProBio Business Overview
11.1.3 GenScript ProBio Fully Humanized Monoclonal Antibody Introduction
11.1.4 GenScript ProBio Revenue in Fully Humanized Monoclonal Antibody Business (2019-2024)
11.1.5 GenScript ProBio Recent Development
11.2 Biotem
11.2.1 Biotem Company Details
11.2.2 Biotem Business Overview
11.2.3 Biotem Fully Humanized Monoclonal Antibody Introduction
11.2.4 Biotem Revenue in Fully Humanized Monoclonal Antibody Business (2019-2024)
11.2.5 Biotem Recent Development
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Details
11.3.2 Creative Biolabs Business Overview
11.3.3 Creative Biolabs Fully Humanized Monoclonal Antibody Introduction
11.3.4 Creative Biolabs Revenue in Fully Humanized Monoclonal Antibody Business (2019-2024)
11.3.5 Creative Biolabs Recent Development
11.4 ProMab Biotechnologies
11.4.1 ProMab Biotechnologies Company Details
11.4.2 ProMab Biotechnologies Business Overview
11.4.3 ProMab Biotechnologies Fully Humanized Monoclonal Antibody Introduction
11.4.4 ProMab Biotechnologies Revenue in Fully Humanized Monoclonal Antibody Business (2019-2024)
11.4.5 ProMab Biotechnologies Recent Development
11.5 ProteoGenix
11.5.1 ProteoGenix Company Details
11.5.2 ProteoGenix Business Overview
11.5.3 ProteoGenix Fully Humanized Monoclonal Antibody Introduction
11.5.4 ProteoGenix Revenue in Fully Humanized Monoclonal Antibody Business (2019-2024)
11.5.5 ProteoGenix Recent Development
11.6 Absolute Antibody
11.6.1 Absolute Antibody Company Details
11.6.2 Absolute Antibody Business Overview
11.6.3 Absolute Antibody Fully Humanized Monoclonal Antibody Introduction
11.6.4 Absolute Antibody Revenue in Fully Humanized Monoclonal Antibody Business (2019-2024)
11.6.5 Absolute Antibody Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Fully Humanized Monoclonal Antibody Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of IgG Type
 Table 3. Key Players of IgM Type
 Table 4. Key Players of IgA Type
 Table 5. Key Players of Others
 Table 6. Global Fully Humanized Monoclonal Antibody Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Fully Humanized Monoclonal Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Fully Humanized Monoclonal Antibody Market Size by Region (2019-2024) & (US$ Million)
 Table 9. Global Fully Humanized Monoclonal Antibody Market Share by Region (2019-2024)
 Table 10. Global Fully Humanized Monoclonal Antibody Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 11. Global Fully Humanized Monoclonal Antibody Market Share by Region (2025-2030)
 Table 12. Fully Humanized Monoclonal Antibody Market Trends
 Table 13. Fully Humanized Monoclonal Antibody Market Drivers
 Table 14. Fully Humanized Monoclonal Antibody Market Challenges
 Table 15. Fully Humanized Monoclonal Antibody Market Restraints
 Table 16. Global Fully Humanized Monoclonal Antibody Revenue by Players (2019-2024) & (US$ Million)
 Table 17. Global Fully Humanized Monoclonal Antibody Market Share by Players (2019-2024)
 Table 18. Global Top Fully Humanized Monoclonal Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fully Humanized Monoclonal Antibody as of 2023)
 Table 19. Ranking of Global Top Fully Humanized Monoclonal Antibody Companies by Revenue (US$ Million) in 2023
 Table 20. Global 5 Largest Players Market Share by Fully Humanized Monoclonal Antibody Revenue (CR5 and HHI) & (2019-2024)
 Table 21. Global Key Players of Fully Humanized Monoclonal Antibody, Headquarters and Area Served
 Table 22. Global Key Players of Fully Humanized Monoclonal Antibody, Product and Application
 Table 23. Global Key Players of Fully Humanized Monoclonal Antibody, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Fully Humanized Monoclonal Antibody Market Size by Type (2019-2024) & (US$ Million)
 Table 26. Global Fully Humanized Monoclonal Antibody Revenue Market Share by Type (2019-2024)
 Table 27. Global Fully Humanized Monoclonal Antibody Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 28. Global Fully Humanized Monoclonal Antibody Revenue Market Share by Type (2025-2030)
 Table 29. Global Fully Humanized Monoclonal Antibody Market Size by Application (2019-2024) & (US$ Million)
 Table 30. Global Fully Humanized Monoclonal Antibody Revenue Market Share by Application (2019-2024)
 Table 31. Global Fully Humanized Monoclonal Antibody Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 32. Global Fully Humanized Monoclonal Antibody Revenue Market Share by Application (2025-2030)
 Table 33. North America Fully Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 34. North America Fully Humanized Monoclonal Antibody Market Size by Country (2019-2024) & (US$ Million)
 Table 35. North America Fully Humanized Monoclonal Antibody Market Size by Country (2025-2030) & (US$ Million)
 Table 36. Europe Fully Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 37. Europe Fully Humanized Monoclonal Antibody Market Size by Country (2019-2024) & (US$ Million)
 Table 38. Europe Fully Humanized Monoclonal Antibody Market Size by Country (2025-2030) & (US$ Million)
 Table 39. Asia-Pacific Fully Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 40. Asia-Pacific Fully Humanized Monoclonal Antibody Market Size by Region (2019-2024) & (US$ Million)
 Table 41. Asia-Pacific Fully Humanized Monoclonal Antibody Market Size by Region (2025-2030) & (US$ Million)
 Table 42. Latin America Fully Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Latin America Fully Humanized Monoclonal Antibody Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Fully Humanized Monoclonal Antibody Market Size by Country (2025-2030) & (US$ Million)
 Table 45. Middle East & Africa Fully Humanized Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 46. Middle East & Africa Fully Humanized Monoclonal Antibody Market Size by Country (2019-2024) & (US$ Million)
 Table 47. Middle East & Africa Fully Humanized Monoclonal Antibody Market Size by Country (2025-2030) & (US$ Million)
 Table 48. GenScript ProBio Company Details
 Table 49. GenScript ProBio Business Overview
 Table 50. GenScript ProBio Fully Humanized Monoclonal Antibody Product
 Table 51. GenScript ProBio Revenue in Fully Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)
 Table 52. GenScript ProBio Recent Development
 Table 53. Biotem Company Details
 Table 54. Biotem Business Overview
 Table 55. Biotem Fully Humanized Monoclonal Antibody Product
 Table 56. Biotem Revenue in Fully Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)
 Table 57. Biotem Recent Development
 Table 58. Creative Biolabs Company Details
 Table 59. Creative Biolabs Business Overview
 Table 60. Creative Biolabs Fully Humanized Monoclonal Antibody Product
 Table 61. Creative Biolabs Revenue in Fully Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)
 Table 62. Creative Biolabs Recent Development
 Table 63. ProMab Biotechnologies Company Details
 Table 64. ProMab Biotechnologies Business Overview
 Table 65. ProMab Biotechnologies Fully Humanized Monoclonal Antibody Product
 Table 66. ProMab Biotechnologies Revenue in Fully Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)
 Table 67. ProMab Biotechnologies Recent Development
 Table 68. ProteoGenix Company Details
 Table 69. ProteoGenix Business Overview
 Table 70. ProteoGenix Fully Humanized Monoclonal Antibody Product
 Table 71. ProteoGenix Revenue in Fully Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)
 Table 72. ProteoGenix Recent Development
 Table 73. Absolute Antibody Company Details
 Table 74. Absolute Antibody Business Overview
 Table 75. Absolute Antibody Fully Humanized Monoclonal Antibody Product
 Table 76. Absolute Antibody Revenue in Fully Humanized Monoclonal Antibody Business (2019-2024) & (US$ Million)
 Table 77. Absolute Antibody Recent Development
 Table 78. Research Programs/Design for This Report
 Table 79. Key Data Information from Secondary Sources
 Table 80. Key Data Information from Primary Sources
 Table 81. Authors List of This Report


List of Figures
 Figure 1. Fully Humanized Monoclonal Antibody Picture
 Figure 2. Global Fully Humanized Monoclonal Antibody Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Fully Humanized Monoclonal Antibody Market Share by Type: 2023 VS 2030
 Figure 4. IgG Type Features
 Figure 5. IgM Type Features
 Figure 6. IgA Type Features
 Figure 7. Others Features
 Figure 8. Global Fully Humanized Monoclonal Antibody Market Size by Application (2024-2030) & (US$ Million)
 Figure 9. Global Fully Humanized Monoclonal Antibody Market Share by Application: 2023 VS 2030
 Figure 10. Laboratory Research Case Studies
 Figure 11. Clinical Drugs Case Studies
 Figure 12. Fully Humanized Monoclonal Antibody Report Years Considered
 Figure 13. Global Fully Humanized Monoclonal Antibody Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 14. Global Fully Humanized Monoclonal Antibody Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Fully Humanized Monoclonal Antibody Market Share by Region: 2023 VS 2030
 Figure 16. Global Fully Humanized Monoclonal Antibody Market Share by Players in 2023
 Figure 17. Global Top Fully Humanized Monoclonal Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fully Humanized Monoclonal Antibody as of 2023)
 Figure 18. The Top 10 and 5 Players Market Share by Fully Humanized Monoclonal Antibody Revenue in 2023
 Figure 19. North America Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. North America Fully Humanized Monoclonal Antibody Market Share by Country (2019-2030)
 Figure 21. United States Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Fully Humanized Monoclonal Antibody Market Share by Country (2019-2030)
 Figure 25. Germany Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. France Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. U.K. Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Italy Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Russia Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Nordic Countries Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Fully Humanized Monoclonal Antibody Market Share by Region (2019-2030)
 Figure 33. China Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Japan Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. South Korea Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Southeast Asia Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. India Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Australia Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Fully Humanized Monoclonal Antibody Market Share by Country (2019-2030)
 Figure 41. Mexico Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Brazil Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Fully Humanized Monoclonal Antibody Market Share by Country (2019-2030)
 Figure 45. Turkey Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Saudi Arabia Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. UAE Fully Humanized Monoclonal Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. GenScript ProBio Revenue Growth Rate in Fully Humanized Monoclonal Antibody Business (2019-2024)
 Figure 49. Biotem Revenue Growth Rate in Fully Humanized Monoclonal Antibody Business (2019-2024)
 Figure 50. Creative Biolabs Revenue Growth Rate in Fully Humanized Monoclonal Antibody Business (2019-2024)
 Figure 51. ProMab Biotechnologies Revenue Growth Rate in Fully Humanized Monoclonal Antibody Business (2019-2024)
 Figure 52. ProteoGenix Revenue Growth Rate in Fully Humanized Monoclonal Antibody Business (2019-2024)
 Figure 53. Absolute Antibody Revenue Growth Rate in Fully Humanized Monoclonal Antibody Business (2019-2024)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS